Antibodies

Israeli startup to use AI to transform antibody discovery, design

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

 AI (Artificial Intelligence) letters and robot hand miniature in this illustration taken, June 23, 2023.
 (l-r) Ariel Tennenhouse, Lev Khmelnitsky, Prof. Sarel Fleishman, Razi Khalaila

Researchers find new way to make animal antibodies safe for humans

 A highly contagious viral disease. Influenza virus

Flu viruses may be combated with new antibody, study finds

ADULTS SHOULD aim for seven to nine hours, and older adults should aim for seven to eight hours.

Sleeping less than six hours will decrease vaccine effectiveness - study


Moderna booster increases antibodies against COVID-19 variants

The booster shots, given to volunteers previously inoculated with Moderna's two-dose vaccine regimen, also boosted antibodies against the original version of COVID-19

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020.

Transplant recipients less likely to develop corona antibodies

Some 138 kidney transplant recipients and 80 liver transplant recipients participated in the study, as well as 25 individuals who did not present similar issues, to act as controls.

A team of surgeons performs an innovative meniscus transplant.

Coronavirus: Israeli study finds vaccine antibodies in breast milk

In addition, Israeli researchers confirmed that the antibodies can block the virus from binding with receptors on host cells, therefore showing the potential to prevent the disease.

Israeli women take part at a Mass Breastfeeding as they gathered at Rabin Square in Tel Aviv on March 18, 2016, the idea  was to promote women's right to breastfeeding their babies in public, March 18, 2016. Photo by Tomer Neuberg/Flash90

Hadassah rolls out outpatient antibody cocktail infusion to reduce COVID

The treatment lasts around three hours, including observation.

THE HADASSAH-UNIVERSITY Medical Center campus is seen in Ein Kerem.

Coronavirus: Antibody cocktail blocks symptomatic infections in trials

It is not a vaccine and is not expected to cause permanent immunity.

Magen David Adom medical team members, wearing protective gear, is handling a Coronavirus test from patients in Jerusalem, on April 17, 2020.

Antibodies increase by 6 to 20 times after second Pfizer dose - Sheba

Results showed that antibodies were higher than those who suffered severe cases of the virus.

Sheba Medical Center team at the Coronavirus isolation ward of Sheba Medical Center unit, in Ramat Gan, June 30, 2020.

Antibody study aims to protect those exposed to coronavirus from illness

Two studies will examine whether an antibody combination reduces the risk of developing COVID-19 and/or reduces the severity of the infection compared to a placebo.

An illustration, created at the Centers for Disease Control and Prevention (CDC), depicts the 2019 Novel Coronavirus

Moderna to use Roche antibody test in coronavirus vaccine trials

Roche’s Elecsys Anti-SARS-CoV-2 test US Food and Drug Administration (FDA) emergency use administration in May.

Roche Diagnostics immunochemistry analyser

Coronavirus humoral immunity may decline in months after infection - study

Researchers called for a larger study of humoral immunity, saying that their small study emphasizes the need for further research.

A medic of the regional hospital receives Russia's "Sputnik V" vaccine shot against the coronavirus disease (COVID-19) in Tver, Russia October 12, 2020.

New study of Ebola may hold answers for long-term COVID-19 immunity

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.

Nano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells leading to activation of T cells to recognize and attack melanoma.